The Elenitoba-Johnson laboratory is focused on elucidation of the mechanisms underlying the development and evolution of human malignant lymphoma, the identification of biomarkers for disease detection, prognosis and targeted therapy. The laboratory also studies the role of post-translational events in the regulation of critical cellular processes and their deregulation in cancer.